Mitchell Chan | CFO |
Bing Yao | Chairman and CEO |
Jörn Drappa | Chief Medical Officer and Head R&D |
Bill Ragatz | SVP, Head Commercial |
Seamus Fernandez | Guggenheim |
Jeff Hung | Morgan Stanley |
Paul Choi | Goldman Sachs |
Joseph Thome | Cowen & Company |
Kenneth Shields | Wedbush Securities |
Derek Archila | Stifel |
Raghuram Selvaraju | H.C. Wainwright |
Yatin Suneja | Guggenheim |
Good afternoon ladies and gentlemen, and welcome to the Viela Bio Third Quarter 2020 Earnings Conference Call. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session and instructions will be given at that time.
As a reminder, this conference call is being recorded. I would now like to hand the call over to Mr.